EUVIMEDEUVIMED entdecken
Crossref

Continuation of antiplatelet and anticoagulant therapy during endoscopic variceal band ligation is not associated with increased rates of post-banding bleeding: an Australian retrospective analysis

Thomas Worland, Samuel Hui, R. Kimberley Chan, Jonathan Ng, Karla Cameron, Catherine Yu, Gabrielle Hoskin, Gordon Chen, Monique Fernandez, Nicola Tomkins, Jack Whitelaw, Marie Sinclair

Clinical Endoscopy · 17.11.2026

DOI: 10.5946/ce.2025.442 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endoscopy, online erschienen am 17.11.2026. Verfasst von Thomas Worland und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims There is little evidence to guide the management of antiplatelets/anticoagulants (AP/AC) during endoscopic variceal band ligation (EVBL). This study aims to assess bleeding complications following EVBL performed with AP/AC.

Methods

We retrospectively assessed all EVBL cases performed at our centre over a 10-year period (January 2010 to August 2020), comparing outcomes of those on AP/AC during EVBL versus those not on AP/AC. Secondary analysis was of patients continuing AP/AC versus those who withheld usual AP/AC.

Results

A total of 1,570 episodes of EVBL were analysed (116 AP/AC, 1,454 off AP/AC). Mean age was 56.2 years, 75.6% were male, and mean model for end stage liver disease score was 14. No difference was found between groups for 30-day bleeding rates (3/116 cases [2.6%] on AP/AC, 52/1,454 cases [3.6%] off AP/AC, p =0.58), or overall 30-day mortality (3/116 cases [2.6%] on AP/AC, 18/1,454 cases [1.2%] off AP/AC, p =0.22). Similarly, 30-day bleeding rates did not differ between AP/AC patients continuing (3/110 cases [2.7%]) versus those withholding therapy (6/123 cases [4.9%], p =0.40).

Conclusions

In a large cohort of patients undergoing EVBL, continuation of AP/AC therapy was not associated with an elevated risk of rebleeding. This adds further evidence to support current recommendations to continue such therapy for patients undergoing endoscopy for varices.

Zitieren

APA

Worland, T., Hui, S., Chan, R. K., Ng, J., Cameron, K., Yu, C., Hoskin, G., Chen, G., Fernandez, M., Tomkins, N., Whitelaw, J., & Sinclair, M. (2026). Continuation of antiplatelet and anticoagulant therapy during endoscopic variceal band ligation is not associated with increased rates of post-banding bleeding: an Australian retrospective analysis. Clinical Endoscopy. https://doi.org/10.5946/ce.2025.442

Vancouver

Worland T, Hui S, Chan RK, Ng J, Cameron K, Yu C, et al. Continuation of antiplatelet and anticoagulant therapy during endoscopic variceal band ligation is not associated with increased rates of post-banding bleeding: an Australian retrospective analysis. Clinical Endoscopy. 2026. doi:10.5946/ce.2025.442

BibTeX
@article{Worland2026,
  author = {Worland, Thomas and Hui, Samuel and Chan, R. Kimberley and Ng, Jonathan and Cameron, Karla and Yu, Catherine and Hoskin, Gabrielle and Chen, Gordon and Fernandez, Monique and Tomkins, Nicola and Whitelaw, Jack and Sinclair, Marie},
  title = {Continuation of antiplatelet and anticoagulant therapy during endoscopic variceal band ligation is not associated with increased rates of post-banding bleeding: an Australian retrospective analysis},
  journal = {Clinical Endoscopy},
  year = {2026},
  doi = {10.5946/ce.2025.442}
}
Kostenlos starten →